Pu Li

Title: **The Innovations of Inventor Pu Li: Enhancing Immunoassay Sensitivity**

Introduction

Pu Li, an accomplished inventor based in San Jose, California, has made significant contributions in the field of immunoassays. With a patent to his name, he focuses on improving the sensitivity of these crucial assays, which play a vital role in diagnostic testing and research.

Latest Patents

Pu Li holds a patent for an **immunoassay with enhanced sensitivity**. This innovative invention is aimed at methods for increasing the sensitivity of immunoassays. The patented method utilizes acid elution conditions that preferentially elute specifically bound immune complexes over non-specifically bound complexes from a solid phase. This design enhances the immunoassay protocols by improving the ratio of specific binding to non-specific binding, thereby significantly raising assay sensitivity. The protocol is designed to accurately determine the signal of labeled immunocomplexes eluted from a solid phase.

Career Highlights

Pu Li is associated with **Access Medical Systems, Ltd.**, where he applies his expertise to develop cutting-edge solutions in medical diagnostics. His background and experience in this field have enabled him to create impactful innovations that improve diagnostic accuracy and reliability.

Collaborations

Throughout his career, Pu Li has collaborated with notable colleagues, including Robert F. Zuk and Hong Tan. These collaborations have facilitated the sharing of knowledge and ideas, driving forward advancements in immunoassay technology and enhancing the overall impact of their collective work.

Conclusion

Pu Li's work exemplifies the dedication and ingenuity of inventors in the field of medical diagnostics. Through his patent for an enhanced sensitivity immunoassay, he demonstrates a commitment to improving diagnostic processes, ultimately contributing to better healthcare outcomes. His collaborations with esteemed colleagues further strengthen the innovations emerging from **Access Medical Systems, Ltd.** and set a foundation for future advancements in the field.